BDXA - Becton, Dickinson and Company

NYSE - NYSE Delayed Price. Currency in USD
61.36
+0.03 (+0.05%)
As of 9:55AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close61.33
Open61.08
BidN/A x N/A
AskN/A x N/A
Day's Range61.08 - 61.41
52 Week Range50.27 - 67.71
Volume6,832
Avg. VolumeN/A
Net AssetsN/A
NAVN/A
PE Ratio (TTM)N/A
YieldN/A
YTD ReturnN/A
Beta (3Y Monthly)N/A
Expense Ratio (net)N/A
Inception DateN/A
Trade prices are not sourced from all markets
  • Market check: talking interest rates and inflation
    Yahoo Finance Video4 months ago

    Market check: talking interest rates and inflation

    Jensen Quality Growth Fund Portfolio Manager Allen Bond talks inflation and interest rates with Yahoo Finance's Adam Shapiro and Julie Hyman and Cumberland Advisors Chairman & Chief Investment Officer David Kotok.

  • Becton, Dickinson Muscles Through a Tough Quarter
    Motley Fool2 months ago

    Becton, Dickinson Muscles Through a Tough Quarter

    Things should pick up in the back half of the fiscal year.

  • TheStreet.com2 months ago

    The Charts of Becton, Dickinson Need More 'Work' Before a Rally

    In this daily bar chart of BDX, below, we can see that prices made a peak in early October and prices weakened into late December/early January. The daily On-Balance-Volume (OBV) line has declined since early April and suggests that sellers of BDX have been more aggressive. In this weekly bar chart of BDX, below, we can see a potential topping or bearish pattern from late 2017 with a possible "neckline" across the $210 level.

  • Benzinga2 months ago

    Jim Cramer Gives His Opinion On Becton Dickinson, Fox, Puma Biotech And More

    On CNBC's "Mad Money Lightning Round,"  Jim Cramer said he would hold off for now from Village Farms International Inc (NASDAQ: VFF ). He is not a buyer of Sailpoint Technologies Holdings Inc ...

  • Benzinga2 months ago

    Barclays Upgrades Becton Dickinson, Says Market Overreacted To FDA's Drug-Coated Balloon Update

    Becton Dickinson and Co’s (NYSE: BDX ) stock has lost more than 10 percent since March 15 in response to the FDA update on drug-coated balloons, or DCBs.  The market seems to have overreacted to the news, ...

  • Becton Dickinson & Co. (BDX) Q2 2019 Earnings Call Transcript
    Motley Fool2 months ago

    Becton Dickinson & Co. (BDX) Q2 2019 Earnings Call Transcript

    BDX earnings call for the period ending March 31, 2019.

  • Associated Press2 months ago

    Becton Dickinson: Fiscal 2Q Earnings Snapshot

    The Franklin Lakes, New Jersey-based company said it had a loss of 7 cents per share. Earnings, adjusted for one-time gains and costs, came to $2.59 per share. The results topped Wall Street expectations. ...

  • TheStreet.com2 months ago

    Becton, Dickinson Expected to Earn $2.58 a Share

    is expected to report quarterly earnings of $2.58 a share on sales of $4.2 billion before the market opens on Thursday, based on a FactSet survey of 19 analysts. The stock has fallen 4.1% since the company last reported earnings on Feb. 5. Becton, Dickinson is currently trading at a price-to-forward-earnings ratio of 17.9 based on the 12-month estimates of 20 analysts surveyed by FactSet.

  • PR Newswire3 months ago

    BD Board Declares Dividends

    FRANKLIN LAKES, N.J. , April 29, 2019 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.77 per common share, payable on June ...

  • Why An FDA Probe Is Rocking The Boat For These Medical Device Makers
    Investor's Business Daily4 months ago

    Why An FDA Probe Is Rocking The Boat For These Medical Device Makers

    A Food and Drug Administration probe into chemotherapy drug paclitaxel is testing the waters for medical device companies SurModics, Boston Scientific, Medtronic and Becton Dickinson.

  • Bard Helps Becton, Dickinson Continue Singing
    Motley Fool5 months ago

    Bard Helps Becton, Dickinson Continue Singing

    Four quarters into the integration, Bard continues to drive top- and bottom-line growth at the combined healthcare company.

  • Why Becton Dickinson Stock Jumped 11% in January
    Motley Fool5 months ago

    Why Becton Dickinson Stock Jumped 11% in January

    Investors were encouraged by a stellar first-quarter earnings report and a solid outlook for the year ahead.

  • Associated Press5 months ago

    Becton Dickinson: Fiscal 1Q Earnings Snapshot

    The Franklin Lakes, New Jersey-based company said it had net income of $2.05 per share. Earnings, adjusted for non-recurring costs and restructuring costs, were $2.70 per share. The medical device manufacturer ...

  • Becton, Dickinson Expected to Continue to Reward Shareholders
    GuruFocus.com6 months ago

    Becton, Dickinson Expected to Continue to Reward Shareholders

    Medical device companies need to focus on value and disease prevention or their products risk becoming commodities, according to a recent report by consulting firm KPMG. Warning! GuruFocus has detected 3 Warning Signs with ZBH.

  • Reuters6 months ago

    Age bias law does not cover job applicants - U.S. appeals court

    A divided U.S. appeals court on Wednesday dealt a setback to older job applicants, saying they cannot invoke a federal law against age bias in employment to challenge hiring policies they believe have a discriminatory impact. In an 8-4 decision, the 7th U.S. Circuit Court of Appeals in Chicago said the "plain language" of the Age Discrimination in Employment Act ("ADEA"), which forbids discrimination against people 40 and older, showed that Congress intended that law to cover current employees, not outside job applicants. It also reinstated a federal district judge's dismissal of Illinois resident Dale Kleber's disparate impact claim against CareFusion Corp, a unit of medical device maker Becton Dickinson and Co.

  • TheStreet.com6 months ago

    Becton Dickinson Expects First-Quarter Earnings to Beat Wall Street Estimates

    said it expects fiscal first-quarter results above Wall Street's expectations. The multinational medical technology company expects quarterly revenue of $4.16 billion for the first fiscal quarter ended Dec. 31, an increase of 35.1% from the prior year, primarily due to the acquisition of C. R. Bard, the company said. Preliminary earnings per share of $2.70 increased 8.9% from $2.48 the prior year, or 14.9% on a currency-neutral basis.

  • GuruFocus.com6 months ago

    52-Week Company Lows

    According to GuruFocus' list of 52-week lows, these Guru stocks have reached their 52-week lows. The price of Becton, Dickinson and Co. (BDX) shares has declined to close to the 52-week low of $216.99, which is 21.5% off the 52-week high of $265.87. The company has a market cap of $58.47 billion.

  • See what the IHS Markit Score report has to say about Becton Dickinson and Co.
    Markit7 months ago

    See what the IHS Markit Score report has to say about Becton Dickinson and Co.

    Becton Dickinson and Co NYSE:BDX

  • MS Global Franchise Fund's Top 5 Buys in 3rd Quarter
    GuruFocus.com8 months ago

    MS Global Franchise Fund's Top 5 Buys in 3rd Quarter

    Fund adds to two existing positions and introduces three new holdings

  • GuruFocus.com8 months ago

    Becton, Dickinson and Co (BDX) Files 10-K for the Fiscal Year Ended on September 30, 2018

    Becton, Dickinson and Co is a healthcare company. The dividend yield of Becton, Dickinson and Co stocks is 1.22%. Becton, Dickinson and Co had annual average EBITDA growth of 4.60% over the past ten years.

  • Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now
    Zacks8 months ago

    Here's Why You Should Hold Becton, Dickinson (BDX) Stock Now

    Solid fiscal Q4 for Becton, Dickinson (BDX); headwinds apprehended in fiscal 2019.

  • Becton, Dickinson Closes Out Its Fiscal Year With a Bang
    Motley Fool8 months ago

    Becton, Dickinson Closes Out Its Fiscal Year With a Bang

    Next year's revenue may not be so hot, but earnings should grow nicely as the company captures synergies and pays down debt.